IL18 and inflammatory bowel disease: In agreement, the favorable role of IL-18 inhibition using neutralizing anti-IL-18 antibodies or IL-18 Binding Protein have been reported in DSS or Trinitrobenzene sodium (TSNBS) induced models of IBD (176, 177).